Journal of Veterinary Internal Medicine,
Journal Year:
2022,
Volume and Issue:
36(2), P. 363 - 378
Published: Feb. 22, 2022
Abstract
Background
Autoantibody
biomarkers
are
valuable
tools
used
to
diagnose
and
manage
autoimmune
diseases
in
dogs.
However,
prior
publications
have
raised
concerns
over
a
lack
of
standardization
sufficient
validation
for
the
use
veterinary
medicine.
Objectives
Systematically
compile
primary
research
on
autoantibody
disease
dogs,
summarize
their
methodological
features,
evaluate
quality;
synthesize
data
supporting
into
resource
veterinarians
researchers.
Animals
Not
used.
Methods
Five
indices
were
searched
identify
studies
evaluation:
PubMed,
CAB
Abstracts,
Web
Science,
Agricola,
SCOPUS.
Two
independent
reviewers
(AET
ELC)
screened
titles
abstracts
exclusion
criteria
followed
by
full‐text
review
remaining
articles.
Relevant
classified
based
study
objectives
(biomarker,
epitope,
technique).
Data
characteristics
outcomes
synthesized
tables
each
classification.
Results
Ninety‐two
qualified
final
analysis
(n
=
49
biomarker,
n
9
34
technique
studies).
A
high
degree
heterogeneity
reporting
was
observed.
Opportunities
strengthen
future
could
include:
(1)
routine
negative
controls,
(2)
power
analyses
inform
sample
sizes,
(3)
statistical
when
appropriate,
(4)
multiple
detection
techniques
confirm
results.
Conclusions
These
findings
provide
that
will
allow
clinicians
efficiently
evidence
biomarkers,
along
with
varied
approaches
development.
JCI Insight,
Journal Year:
2025,
Volume and Issue:
10(2)
Published: Jan. 22, 2025
Autoimmune
uveitis
(AU)
is
a
sight-threatening
ocular
autoimmune
disorder
that
often
manifests
as
retinal
vasculitis.
Increased
neutrophil
infiltration
around
vessels
has
been
reported
during
the
progression
of
AU,
while
how
they
function
not
fully
recognized.
Neutrophil
extracellular
traps
(NETs),
produced
by
activated
neutrophils,
have
suggested
to
be
detrimental
in
diseases.
Here,
we
found
NETs
were
elevated
patients
with
active
and
this
was
verified
an
experimental
AU
(EAU)
mouse
model.
Depletion
neutrophils
or
degradation
deoxyribonuclease-I
(DNase
I)
could
decrease
CD4+
effector
T
cell
(Teff)
retina
spleen
alleviate
EAU.
Moreover,
expression
adhesion
molecules,
selectin,
antigen-presenting
molecules
EAU
microvascular
endothelial
cells
(RMECs)
cocultured
NETs.
The
stimulated
RMECs
further
facilitated
adhesion,
activation,
differentiation
into
Teffs.
Mechanistically,
trigger
RMEC
activation
hastening
senescence
through
cyclic
GMP-AMP
synthase
(cGAS)/stimulator
interferon
genes
(STING)
pathway.
Slowing
down
inhibiting
cGAS/STING
pathway
reduces
cells.
These
results
suggest
deleterious
role
AU.
Targeting
would
offer
effective
therapeutic
method.
Frontiers in Pharmacology,
Journal Year:
2022,
Volume and Issue:
13
Published: Sept. 13, 2022
Membranous
nephropathy
(MN)
is
a
renal-limited
non-inflammatory
autoimmune
disease
in
the
glomerulus,
which
second
or
third
main
cause
of
end-stage
kidney
diseases
patients
with
primary
glomerulonephritis.
Substantial
achievements
have
increased
our
understanding
aetiology
and
pathogenesis
murine
human
MN.
The
identification
nephritogenic
autoantibodies
against
neutral
endopeptidase,
phospholipase
A
2
receptor
(PLA
R)
thrombospondin
type-1
domain-containing
7A
(THSD7A)
antigens
provide
more
specific
concept-driven
intervention
strategies
for
treatments
by
B
cell-targeting
monoclonal
antibodies
to
inhibit
antibody
production
antibody-antigen
immune
complex
deposition.
Furthermore,
additional
specificities
been
discovered,
but
their
pathogenic
effects
are
uncertain.
Although
anti-PLA
R
anti-THSD7A
as
diagnostic
marker
widely
used
MN
patients,
many
questions
including
response
development,
antigenic
epitopes,
podocyte
damage
signalling
pathways
remain
unresolved.
This
review
describes
current
available
evidence
regarding
both
established
novel
molecular
mechanisms
based
on
systems
biology
approaches
(gut
microbiota,
long
non-coding
RNAs,
metabolite
biomarkers
DNA
methylation)
MN,
an
emphasis
clinical
findings.
further
summarizes
applications
traditional
Chinese
medicines
such
Tripterygium
wilfordii
Astragalus
membranaceus
treatment.
Lastly,
this
considers
how
antibodies/antigens
unresolved
future
challenges
reveal
Frontiers in Pharmacology,
Journal Year:
2022,
Volume and Issue:
13
Published: May 26, 2022
Membranous
nephropathy
(MN)
is
the
most
common
cause
of
nephrotic
syndrome
among
adults,
which
leading
glomerular
disease
that
recurs
after
kidney
transplantation.
Treatment
for
MN
remained
controversial
and
challenging,
partly
owing
to
absence
sensitive
specific
biomarkers
effective
therapy
prediction
diagnosis
activity.
starts
with
formation
deposition
circulating
immune
complexes
on
outer
area
in
basement
membrane,
complement
activation.
The
identification
autoantibodies
against
phospholipase
A2
receptor
(PLA2R)
thrombospondin
type-1
domain-containing
protein
7A
(THSD7A)
antigens
illuminated
a
distinct
pathophysiological
rationale
treatments.
Nowadays,
detection
serum
anti-PLA2R
antibodies
deposited
PLA2R
antigen
can
be
routinely
applied
MN.
Anti-PLA2R
exhibited
much
high
specificity
sensitivity.
Measurement
complex
allows
PLA2R-associated
patients
renal
biopsies.
In
review,
we
critically
summarized
newer
including
THSD7A
tests
novel
promising
therapies
by
using
traditional
Chinese
medicines
such
as
Astragalus
membranaceus,
Tripterygium
wilfordii,
Astragaloside
IV
treatment
patients.
We
also
described
unresolved
questions
future
challenges
reveal
treatments
These
unprecedented
breakthroughs
were
quickly
translated
clinical
management.
Considerable
advances
methods
played
critical
role
monitoring
treatment.
Journal of Biochemical and Molecular Toxicology,
Journal Year:
2025,
Volume and Issue:
39(1)
Published: Jan. 1, 2025
Phospholipase
A2
receptor
1
(PLA2R1)
exists
in
many
animals
and
plays
an
important
role
membranous
nephropathy.
In
this
study,
we
aimed
to
evaluate
a
PLA2R1
knock-in
rat
model
with
repaired
kidney
function
study
the
molecular
mechanisms
of
We
constructed
knockout
[PLA2R1(-)]
knock
[PLA2R1(+)]
rats.
Consistent
complement
C3
IgA
expression
was
confirmed
through
colocalization
studies.
Urinary
biochemical
indicators
were
performed
using
Automatic
Biochemistry
Analyzer.
The
C3,
IgG,
Nephrin
detected
by
immunofluorescence
assay.
levels
IgA,
western
blot.
differential
proteins
(DEPs)
between
control
PLA2R1(+)
models
liquid
chromatography
tandem
mass
spectrometry.
PLA2R1(-)
showed
proteinuria,
aggregation,
IgG
deposition
glomerulus.
Comparing
model,
glomerulus
did
not
completely
disappear,
weakened.
Moreover,
absolute
value
urinary
protein
much
lower
than
some
humanized
gene
fragments
functions.
Humanized
PLA2R1-insertion
rats
can
repair
part
renal
reduce
which
will
help
studying
nephropathy,
as
well
entire
nephropathy-related
system
activation
signaling
pathway.
Genes,
Journal Year:
2025,
Volume and Issue:
16(3), P. 241 - 241
Published: Feb. 20, 2025
Background/Objectives:
Autoimmunity
towards
podocyte
antigens
causes
membranous
nephropathy
(MN).
Numerous
MN
target
(MNTAgs)
have
been
reported,
including
PLA2R1,
THSD7A,
NTNG1,
TGFBR3,
HTRA1,
NDNF,
SEMA3B,
FAT1,
EXT1,
CNTN1,
NELL1,
PCDH7,
EXT2,
PCSK6,
and
NCAM1,
but
their
expression
has
not
thoroughly
studied.
Methods:
We
screened
CZ
CELLxGene
single-cell
RNA
(scRNA)
sequence
datasets
for
those
of
adult,
fetal,
mouse
kidneys
analyzed
the
above
MNTAgs’
expression.
Results:
In
adult
kidneys,
most
MNTAgs
are
present
in
podocytes,
except
PCSK6
NCAM1.
PLA2R1
is
expressed
significantly
more
than
other
podocytes
a
major
marker,
consistent
with
as
dominant
MNTAg.
Additionally,
top-upregulated
gene
chronic
kidney
disease,
acute
injury,
diabetic
nephropathy,
indicating
its
general
role
causing
injury.
NDNF
display
podocyte-enriched
along
elevated
chromatin
accessibility
suggesting
transcription
initiation
contributing
to
preference
podocytes.
fetal
kidney,
While
weakly
SEMA3B
abundantly
immature
mature
supporting
childhood
Thsd7a
only
MNTAg
prominent
level
podocyte-specific
Conclusions:
Most
adults
during
renal
development.
adults,
highly
enriched
upregulated
multiple
diseases
accompanied
by
proteinuria.
specifically
at
an
level.
Psychiatry and Clinical Neurosciences Reports,
Journal Year:
2025,
Volume and Issue:
4(1)
Published: Feb. 19, 2025
The
aim
of
this
study
was
to
provide
new
insights
into
the
genetics
bipolar
disorder
(BD)
by
analyzing
BD
comorbid
with
anxiety
disorders.
Structured
interviews
were
conducted
patients
and
their
parents.
Cases
classified
those
spectrum
(AS)
without.
family
history
AS
assessed.
Focusing
on
parent-of-origin
effects
genomic
imprinting
from
results,
imprinted
genes
tested
single
nucleotide
polymorphisms
(SNPs)
in
identified
investigated
for
an
association
transmission
disequilibrium
test
(TDT)
using
published
whole-exome
sequencing
data.
incidence
among
all
analyzed
39.6%.
Patients
whose
fathers
had
or
mood
disorders
exhibited
a
significantly
higher
rate
AS.
Among
known
genes,
two
associated
BD:
THSD7A
CACNA1C.
By
pruning
SNPs,
six
variants
exons
four
CACNA1C
included
analysis.
these,
one
variant
THSD7A,
rs2074603,
showed
over-transmission
parents
BD.
Furthermore,
it
nominally
significant
only
when
TDT
performed
separately
mothers.
may
play
role
effects.
Further
research
is
necessary
explore
mechanisms
which
Clinical
Trial
Registration:
N/A.
Venous
thromboembolism
(TE)
and
arterial
TE
are
rare
in
children,
but
can
cause
severe
morbidity
mortality.
The
incidence
of
is
8.6-57
per
100
000
among
hospitalized
children
0.14-0.9
the
general
pediatric
population.
risk
increased
nephrotic
syndrome
(NS)
patients.
thromboembolic
complications
NS
patients
approximately
3%.
Herein
we
report
a
patient
that
presented
with
massive
bilateral
pulmonary
embolism
(PE)
whom
underlying
condition
was
NS.
At
onset
clinical
course
findings
were
attributed
to
heart
failure
and,
therefore,
diagnosis
treatment
delayed.
Based
on
case,
think
clinicians
should
consider
PE
when
hypoalbuminemia,
diffuse
edema,
proteinuria
present,
timely
initiation
concomitant
administration
yield
positive
results.
We
further
diagnosed
have
generalized
be
considered
for
started
without
delay
concomitantly
order
achieve
result.
Kazan medical journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
This
literature
review
analyzes
the
results
of
international
studies
conducted
over
past
five
years,
focusing
on
glomerulopathies
associated
with
malignant
neoplasms
various
locations.
The
aim
this
is
to
conduct
a
comparative
analysis
histological
and
immunohistochemical
features
morphological
characteristics
in
across
locations,
as
well
determine
specificity
identified
features.
research
data
were
retrieved
using
Scopus,
PubMed,
Cochrane
Library
databases,
limited
publications
from
2019
2024.
study
provided
detailed
changes
glomerular
apparatus
carcinomas
evaluated
described
Special
attention
was
given
pathogenetic
mechanisms
hypothesized
explain
development
different
A
topic
demonstrates
that
understanding
contributes
improvement
diagnostic
methods
for
such
conditions.
importance
field
cannot
be
overstated,
it
may
provide
new
insights
developing
innovative
approaches
aimed
at
enhancing
prognosis
quality
life
patients
oncological
diseases.
Malignant
tumor
cells
can
express
substances,
including
proteins,
which
lead
glomerulopathy.
Analysis
helps
identify
presence
or
absence
link
between
glomerulopathy,
enabling
adjustments
patient’s
treatment
plan.
Additionally,
part
focuses
exploring
potential
pathophysiological
underlying
neoplasms,
facilitates
more
accurate
diagnosis
distinguishes
specific
nonspecific
characteristics.
Thus,
provides
an
emphasizing
interdisciplinary
approach
diagnosing
condition
one
clinical
manifestations
tumors.